Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy.

Biomedicines · 2024 · PMC10968142 · PMID 38540301

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The study is important for the patients with NSCLC, because it showed for the first time that in the curative situation, an immune checkpoint inhibitor improved survival with a statistically highly significant increase.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.